TipRanks
Advertisement
Advertisement
Faeth Therapeutics initiated with a Buy at TD Cowen
PremiumThe FlyFaeth Therapeutics initiated with a Buy at TD Cowen
8d ago
Faeth Therapeutics announces inducement grants under Nasdaq listing rule
Premium
The Fly
Faeth Therapeutics announces inducement grants under Nasdaq listing rule
20d ago
Faeth Therapeutics initiated with a Buy at Needham
Premium
The Fly
Faeth Therapeutics initiated with a Buy at Needham
27d ago
BTIG Reiterates Buy on PIKTOR as New PK/PD Data De-Risk Development and Support Unchanged $55 Price Target
PremiumRatingsBTIG Reiterates Buy on PIKTOR as New PK/PD Data De-Risk Development and Support Unchanged $55 Price Target
1M ago
Faeth Therapeutics: Buy Rating Reiterated as PIKTOR Advances in Key Oncology Trials; $60 Price Target Maintained
Premium
Ratings
Faeth Therapeutics: Buy Rating Reiterated as PIKTOR Advances in Key Oncology Trials; $60 Price Target Maintained
1M ago
Faeth Therapeutics management to meet with BTIG
Premium
The Fly
Faeth Therapeutics management to meet with BTIG
1M ago
Faeth Therapeutics initiated with an Outperform at Oppenheimer
PremiumThe FlyFaeth Therapeutics initiated with an Outperform at Oppenheimer
2M ago
Faeth Therapeutics Adopts Performance-Based Stock Option Plan
Premium
Company Announcements
Faeth Therapeutics Adopts Performance-Based Stock Option Plan
2M ago
Faeth Therapeutics initiated with an Outperform at Citizens
Premium
The Fly
Faeth Therapeutics initiated with an Outperform at Citizens
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100